|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/439 | (2006.01) |
| A61K 9/0048 | (2013.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61K 9/08 | (2013.01) | ||
| A61K 9/0043 | (2013.01) | ||
| A61K 31/4427 | (2006.01) | ||
| A61K 31/439 | (2013.01) | ||
| A61K 31/4985 | (2006.01) | ||
| A61K 31/4995 | (2006.01) | ||
| A61K 31/4439 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/4427 | (2013.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61K 31/4985 | (2013.01) | ||
| A61P 11/02 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 31/4995 | (2013.01) | ||
| A61K 31/55 | (2006.01) | ||
| A61P 11/02 | (2018.01) | ||
| A61K 31/436 | (2006.01) | ||
| A61P 25/02 | (2018.01) | ||
| A61P 25/02 | (2006.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61K 38/13 | (2006.01) | ||
| A61K 31/55 | (2013.01) | ||
| A61K 9/08 | (2006.01) | ||
| A61K 38/13 | (2013.01) | ||
| A61K 31/436 | (2013.01) |
| (11) | Patento numeris | 3848028 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20212556.3 |
| Europos patento paraiškos padavimo data | 2015-10-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-07-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-05-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201462066280 P | 2014-10-20 | US | |
| 201562100844 P | 2015-01-07 | US |
| (72) |
ACKERMANN, Douglas Michael, Jr. , US
LOUDIN, James , US
MANDELL, Kenneth J. , US
|
| (73) |
Oyster Point Pharma, Inc. ,
202 Carnegie Center, Suite 109, Princeton, New Jersey 08540,
US
|
| (54) | METHODS OF TREATING OCULAR CONDITIONS |
| METHODS OF TREATING OCULAR CONDITIONS |